The Epidemiology of Drug Abuse.
adolescent health
cannabis
drug abuse
epidemiology
illicit drugs
nicotine
opioids
substance use
Journal
Journal of clinical pharmacology
ISSN: 1552-4604
Titre abrégé: J Clin Pharmacol
Pays: England
ID NLM: 0366372
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
18
03
2021
accepted:
02
07
2021
entrez:
16
8
2021
pubmed:
17
8
2021
medline:
24
8
2021
Statut:
ppublish
Résumé
Many Americans use alcohol and recreational drugs. Some will develop substance use disorders that affect a person's brain and behavior, leading to continued use despite problems caused. We review the epidemiology of addiction in the United States, including changes in use patterns over time, highlighting rates in adolescents and young adults, as well as adults. An overview of the health and societal impacts of substance use is provided alongside the importance of multimodal, evidence-based treatment comprising psychosocial interventions and medication management. The article concludes by exploring the impact of the coronavirus disease 2019 pandemic on people who use drugs and their access to treatment.
Substances chimiques
Illicit Drugs
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S10-S17Informations de copyright
© 2021, The American College of Clinical Pharmacology.
Références
Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services; 2020.
HHS Press Office. HHS Acting Secretary Declares Public Health Emergency to Address National Opioid Crisis. https://www.hhs.gov/opioids/about-the-epidemic/index.html. Accessed March 2, 2021.
Ornell F. Moura HF. Scherer JN, et al. The COVID-19 pandemic and its impact on substance use: implications for prevention and treatment. Psychiatr Res. 2020; 289:113096.
Hasin DS, Grant BF. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) waves 1 and 2: review and summary of findings. Social Psychiatr Psychiatr Epidemiol. 2015;50:1609-1640.
Johnston LD, Miech R A O'Malley, et al. Monitoring the future national survey results on drug use, 1975-2019: overview, key findings on adolescent drug use. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 124. http://monitoringthefuture.org/pubs/monographs/mtf-overview2019.pdf. Accessed March 2, 2021.
Degenhardt L, Stockings E, Patton G, et al. The increasing global health priority of substance use in young people. Lancet Psychiatry. 2016;3(3):251-264.
Han B, Volkow ND, Compton WM, et al. Reported heroin use, use disorder, and injection among adults in the United States, 2002-2018. JAMA. 2020;323(6):568.
Phillips JK, Ford MA, Bonnie RJ. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use. Washington, DC: National Academies Press; 2017.
Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics. http://wonder.cdc.gov. Published 2020. Accessed March 2, 2021.
Wilson N, Kariisa M, Seth P, et al. Drug and opioid-involved overdose deaths-United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020;69:290-297.
United Nations Office on Drugs and Crime. World Drug Report 2020. Booklet 5: Socioeconomic characteristics and drug use disorders. United Nations publication, Sales No. E.20.XI.6
Tirado-Munoz, J. “Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional study,” Arch Women's Ment Health 2018;21(3):259-269.
International Narcotics Control Board. Annual Report 2013: Economic Consequences Of Drug Abuse. New York: United Nations; 2014.
Ritchie H, Roser M. Drug use. https://ourworldindata.org/drug-use. Published 2019. Accessed March 15, 2021.
Roth GA, Abate D, Abate KH, et al. Global, regional and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Diseases Study 2017. Lancet. 2018;392(10159):1736-1788.
Vos, T, Lim, SS, Abbafati, C; GBD 2019 Diseases and Injuries Collaborators, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258): 1204-1222.
Global status report on alcohol and health 2018: Executive summary. Geneva. World Health Organization; 2018: MD/MSB18.2. Licene CC BY-NC-SA 3.0 IGO.
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Results From the 2015 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration;. 2016.
Centers for Disease Control and Prevention. HIV surveillance report: diagnoses of HIV infection in the United States and dependent areas, 2017. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2017-vol-29.pdf. Accessed March 15, 2021.
Roussos-Ross, K., Reisfield, G., Elliot, I., et al. Opioid use in pregnant women and the increase in neonatal abstinence syndrome: What is the cost? J Addict Med. 2015;9(3):222-225.
National Drug Intelligence Center. National Threat Assessment: The Economic Impact of Illicit Drug Use on American Society. Washington, DC: Department of Justice; 2011.
Sacks JJ, Gonzales KR, Bouchery EE, et al. National and state costs of excessive alcohol consumption. Am J Prev Med. 2015;49(5):E73-79.
Xu X, Bishop EE, Kennedy SM, et al. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med. 2015; 49(3):326-333.
Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality. The DAWN Report: Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2021.
Mancher M, Leshner AI; National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Medication-Assisted Treatment for Opioid Use Disorder. Medications for Opioid Use Disorder Save Lives. Washington (DC): National Academies Press (US); 2019.
Patrick SW, Buntin MB, Martin PR, et al. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states. Subst Abus. 2019;40(3):356-362.
Jordan, A, Mathis, M, Haeny, A. et al. An evaluation of opioid use in Black communities: a rapid review of the literature. Harv Rev Psych. 2021;29(2):108-130.
Binswanger IA, Stern MF, Deyo RA, et al. Release from prison-A high risk of death for former inmates. N Engl J Med. 2007;356(2):157-165.
Alinksy RH, Zima BT, Rodean J, et al. Receipt of addiction treatment after opioid overdose among medicaid-enrolled adolescents and youth adults. JAMA Pediatr. 2020;174(3):e1955183.
Lindson N, Chepkin SC, Ye W, et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019;4:CD013308.
Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol. 2001;62(2):211-220.
Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database Syst Rev. 2020;3(3):CD012880.
Kakko J, Svanbord KD, Kreek MJ, Heiling M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomized, placebo-controlled trial. Lancet. 2003;361(9358):662-668.
McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689-1695.
McPherson SM, Burduli E, Lederhos Smith C, et al. A review of contingency management for the treatment of substance-use disorders: adaption for underserved populations, use of experimental technologies, and personalized optimization strategies. Subst Abuse Rehabil. 208;9:43-57.
Compton WM, Blanco C, Wargo EM. Integrating addiction services into general medicine. JAMA. 2015;314(22):2401-2402.
National Institute of Drug Abuse. Monitoring the Future Survey Results. https://www.drugabuse.gov/drug-topics/related-topics/trends-statistics/infographics/monitoring-future-2020-survey-results. Published 2021. Accessed March 2, 2021.
Czeisler ME, Lane RI, Petrosky E, et al. Mental health, substance use and suicidal ideation during the COVID-19 pandemic - United States. MMWR Morb Mortal Wkly Rep. 2020;69:1049-1057.
Canadian Centre on Substance Use and Addiction. Impacts of the COVID-19 Pandemic on Substance Use Treatment Capacity in Canada. https://ccsa.ca/sites/default/files/2020-12/CCSA-COVID-19-Impacts-Pandemic-Substance-Use-Treatment-Capacity-Canada-2020-en.pdf. Published 2021. Accessed March 2, 2021.
Hulsey J, Mellis A, Kelly B. COVID-19 pandemic impact on patients, families and individuals in recovery from substance use disorders. Addiction Policy Forum. https://54817af5-b764-42ff-a7e2-97d6e4449c1a.usrfiles.com/ugd/54817a_7ff82ba57ba14491b888d9d2e068782f.pdf. Published 2021. Accessed March 2, 2021.
Groshkova T, Stoian T, Cunningham A, Griffiths P, Singleton N, Sedefov R. Will the current COVID-19 pandemic impact on long-term cannabis buying practices? J Addict Med. 2020;14(4):e13-0.
Wainwright JJ, Mikre M, Whitley BA, et al. Analysis of drug test results before and after the US Declaration of a National Emergency Concerning the COVID-19 outbreak. JAMA. 2020;324(16):1674-1677.
Millenium Health. Millennium Health's Signals Report™ COVID-19 Special Edition reveals significant changes in drug use during the pandemic. https://www.prnewswire.com/news-releases/millennium-healths-signals-report-covid-19-special-edition-reveals-significant-changes-in-drug-use-during-the-pandemic-301089684.html. Published 2021. Accessed March 2, 2021.
CDC Health Alert Network. Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic. https://emergency.cdc.gov/han/2020/han00438.asp. Published 2021. Accessed March 2, 2021.
Alter A, Yeager C. COVID-19 impact on US national overdose crisis. http://www.odmap.org/Content/docs/news/2020/ODMAP. Published 2021. Accessed March 2, 2021.
Friedman J, Beletsky L, Schriger DL. Overdose-related cardiac arrests observed by emergency medical services during the US COVID-19 Epidemic. JAMA Psychiatry. 2021;78(5):562-564.
Hulsey J, Mellis A, Kelly B. COVID-19 Pandemic impact on patients, families and individuals in recovery from substance use disorders. Addiction Policy Forum. https://54817af5-b764-42ff-a7e2-97d6e4449c1a.usrfiles.com/ugd/54817a_7ff82ba57ba14491b888d9d2e068782f.pdf. Published 2020. Accessed online March 2, 2021.
Fiscella K, Wakeman S, Beletsky L. Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: X the X Waiver. JAMA Psychiatry. 2019;76(3):229-230.